Consider fertility-preserving medications when treating adenomyosis
Authors:
- 5 August 2024
- journal article
- review article
- Published by Springer Nature in Drugs & Therapy Perspectives
- Vol. 40 (9) , 357-362
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Current Medical Therapy for Adenomyosis: From Bench to BedsideDrugs, 2023
- Modern view on the diagnostics and treatment of adenomyosisArchives of Gynecology and Obstetrics, 2023
- A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosisReproductive Medicine and Biology, 2021
- Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trialInternational Journal of Gynecology & Obstetrics, 2021
- Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasoundEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2020
- OP30.04: Changes in the sonographic characteristics of adenomyosis after treatment with ulipristal acetateUltrasound in Obstetrics & Gynecology, 2016
- Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trialContraception, 2015
- Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trialArchives of Gynecology and Obstetrics, 2015
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosisContraception, 2009
- A pilot study on the off-label use of valproic acid to treat adenomyosisFertility and Sterility, 2008